TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    The Smart Money Is Buying Valeant Pharmaceuticals Intl Inc.: Should You Buy Too?

    Famed mutual fund manager Francis Chou is buying Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX). What does he see in the troubled…

    Read more »

    The Motley Fool
    Investing

    Can Valeant Pharmaceuticals Intl Inc. Recover From its Implosion?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) might seem like it's on its last breath, but it has made smart moves that…

    Read more »

    The Motley Fool
    Dividend Stocks

    How Will a Trump or Clinton Presidency Affect Your Portfolio?

    Do you own Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) or TransCanada Corporation (TSX:TRP)(NYSE:TRP) shares? Then pay attention to this election cycle.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: This Risky Stock Has Huge Upside

    After falling 90%, Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has been written off for dead. But perhaps value investors might want…

    Read more »

    The Motley Fool
    Investing

    Has Valeant Pharmaceuticals Intl Inc. Hit the Bottom Yet?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) may have lost over 90% in value over the past year, but the company continues…

    Read more »

    The Motley Fool
    Investing

    What Can Investors Expect From Valeant Pharmaceuticals Intl Inc.?

    Because of high debt, a money-losing partnership, and questions about whether or not insiders have faith, I say avoid Valeant…

    Read more »

    The Motley Fool
    Investing

    How Valeant Pharmaceuticals Intl Inc. Could Become a Great Investment

    Beleaguered Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is starting to make amends for the epic collapse of the stock over the…

    Read more »

    Investing

    3 Companies Actually Investing in the Future

    While analysts at the Bank of Canada and big banks such as Canadian Imperial Bank of Commerce (TSX:CM)(NYSE:CM) are seeing…

    Read more »

    The Motley Fool
    Dividend Stocks

    Brexit: 4 Negative Effects on the Stock Market

    The Brexit added volatility to the stock market, but selective groups of stocks are more vulnerable to declines, including cyclical…

    Read more »

    The Motley Fool
    Investing

    Can Investors Expect Anything Good From Valeant Pharmaceuticals Intl Inc.?

    While Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) won't default, it needs to show that it can be profitable and pay down…

    Read more »

    The Motley Fool
    Investing

    Can Valeant Pharmaceuticals Intl Inc. Recover?

    Shares of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) tumbled this week on reports that it cut 2016 profit forecasts, prompting investors…

    Read more »

    The Motley Fool
    Investing

    3 TSX Stocks That Are Down but Not out

    There are 32 TSX stocks down at least 5% year-to-date, including Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), which is off a…

    Read more »